A new COVID variant called XEC has been spreading around the globe as respiratory virus season begins — and many public ...

Only 13.4% immunocompromised adult US veterans younger than 50 years received the recombinant zoster vaccine by mid-2023, ...

The new drug would allow patients to produce the needed clotting protein for an extended period, reducing the need for ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

A delegation headed by deputy health minister Alireza Raeisi participated in the 14th Meeting of Ministers of Health in ...

Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved HYMPAVZI™ ...

The FDA has approved Pfizer’s marstacimab under the brand name Hympavzi for adults and children with hemophilia A or B, ...

Researchers are learning more about enhanced flu vaccines. Learn what the latest findings show, how available the vaccines are, and who should consider getting one.

China-ASEAN Belt and Road Joint Laboratory on Mariculture Technology, Guangzhou, China ...

The FDA will decide on new drugs for rosacea, AADC deficiency, breast cancer, transthyretin amyloid cardiomyopathy, and biliary tract cancer.

Pharming Group (NASDAQ:PHAR – Get Free Report)‘s stock had its “buy” rating restated by research analysts at HC Wainwright in a research note issued to investors on Thursday, Benzinga reports. They ...